ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications.
van Gelder
T
T
Department of Internal Medicine (T.vG.), University Hospital Rotterdam, Rotterdam, The Netherlands. vangelder@INW1.AZR.NL
Klupp
J
J
Sawamoto
T
T
Christians
U
U
Morris
R E
RE
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D018528:ATP-Binding Cassette Transporters / Q000378:metabolism*; D000818:Animals; D019703:Calcineurin / Q000378:metabolism*; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D018432:Drug Resistance, Multiple; D006084:Graft Rejection / Q000276:immunology / Q000503:physiopathology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D016377:Organ Transplantation; D016559:Tacrolimus / Q000494:pharmacology / Q000627:therapeutic use; D014181:Transplantation Immunology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018528:ATP-Binding Cassette Transporters; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D009173:Mycophenolic Acid; D016559:Tacrolimus